BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7772301)

  • 41. Purification of chicken gizzard myosin light-chain kinase, and its calcium and strontium sensitivities as compared with those of superprecipitation and ATPase activities of actomyosin.
    Uchiwa H; Kato T; Onishi H; Isobe T; Okuyama T; Watanabe S
    J Biochem; 1982 Jan; 91(1):273-82. PubMed ID: 6461641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple specificities of brain Ca2+- and calmodulin-dependent protein kinase for substrate.
    Fukunaga K; Yamamoto H; Iwasa Y; Miyamoto E
    Life Sci; 1982 Jun; 30(23):2019-24. PubMed ID: 6180275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
    Walsh MP; Sutherland C; Scott-Woo GC
    Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MS-347a, a new inhibitor of myosin light chain kinase from Aspergillus sp. KY52178.
    Nakanishi S; Ando K; Kawamoto I; Matsuda Y
    J Antibiot (Tokyo); 1993 Dec; 46(12):1775-81. PubMed ID: 8294233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and sequencing of radish seed calmodulin antagonists phosphorylated by calcium-dependent protein kinase.
    Polya GM; Chandra S; Condron R
    Plant Physiol; 1993 Feb; 101(2):545-51. PubMed ID: 8278508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of calmodulin-dependent myosin light-chain kinase by growth-hormone-releasing factor and vasoactive intestinal peptide.
    Shiraga H; Stallwood D; Ebadi M; Pfeiffer R; Landers D; Paul S
    Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):901-5. PubMed ID: 8010976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of novel classes of protein kinase inhibitors using combinatorial peptide chemistry based on functional genomics knowledge.
    Lukas TJ; Mirzoeva S; Slomczynska U; Watterson DM
    J Med Chem; 1999 Mar; 42(5):910-9. PubMed ID: 10072688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Affinity labelling of smooth-muscle myosin light-chain kinase with 5'-[p-(fluorosulphonyl)benzoyl]adenosine.
    Komatsu H; Ikebe M
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):53-8. PubMed ID: 8250857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of wheat embryo calcium-dependent protein kinase by acridines and azaacridines.
    Chen Q; Deady LW; Polya GM
    Phytochemistry; 1994 Jul; 36(5):1153-9. PubMed ID: 7765360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design of peptidase-resistant peptide inhibitors of myosin light chain kinase.
    Khapchaev AY; Kazakova OA; Samsonov MV; Sidorova MV; Bushuev VN; Vilitkevich EL; Az'muko AA; Molokoedov AS; Bespalova ZD; Shirinsky VP
    J Pept Sci; 2016 Nov; 22(11-12):673-681. PubMed ID: 27699916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A possible role for Ca(2+)/calmodulin-dependent protein kinase IV during pancreatic acinar stimulus-secretion coupling.
    Yoshida H; Nozu F; Lankisch TO; Mitamura K; Owyang C; Tsunoda Y
    Biochim Biophys Acta; 2000 Jun; 1497(1):155-67. PubMed ID: 10838169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myosin light chain kinase autoregulatory pseudosubstrate prototope.
    Pearson RB; Hunt JT; Mitchelhill KI; Kemp BE
    Pept Res; 1991; 4(3):147-53, 156-7. PubMed ID: 1823185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biochemical characterization of galloyl pedunculagin (ellagitannin) as a selective inhibitor of the beta-regulatory subunit of A-kinase in vitro.
    Kosuge S; Maekawa T; Saito C; Tanaka T; Kouno I; Ohtsuki K
    J Biochem; 2001 Mar; 129(3):403-9. PubMed ID: 11226880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitors of myosin light chain kinase and phosphodiesterase reduce ventilator-induced lung injury.
    Parker JC
    J Appl Physiol (1985); 2000 Dec; 89(6):2241-8. PubMed ID: 11090574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substrate based inhibitors of smooth muscle myosin light chain kinase.
    Moreland S; Ikebe M; Hunt JT; Moreland RS
    Biochem Biophys Res Commun; 1992 May; 185(1):379-85. PubMed ID: 1599475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of myosin light chain kinase by amiloride.
    Higashihara M
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1253-9. PubMed ID: 2527500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained muscle contraction induced by agonists, growth factors, and Ca(2+) mediated by distinct PKC isozymes.
    Murthy KS; Grider JR; Kuemmerle JF; Makhlouf GM
    Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G201-10. PubMed ID: 10898764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KT5926, a potent and selective inhibitor of myosin light chain kinase.
    Nakanishi S; Yamada K; Iwahashi K; Kuroda K; Kase H
    Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclic AMP-dependent protein kinase A plays a role in the directed migration of human keratinocytes in a DC electric field.
    Pullar CE; Isseroff RR; Nuccitelli R
    Cell Motil Cytoskeleton; 2001 Dec; 50(4):207-17. PubMed ID: 11807941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.